✦ LIBER ✦

Evaluation of Rabbit Antithymocyte Globulin (rATG) Dose-Intensity in Patients Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Reduced Intensity Conditioning (RIC) with Fludarabine, Busulfan and rATG (FBA)

✍ Scribed by M. Hamadani; D.M. Benson Jr.; P. Porcu; P. Elder; L. Andritsos; C.C. Hofmeister; D. Krugh; R. Garzon; T. Lin; G. Marcucci; W. Blum; S.M. Devine

Book ID: 116280544
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 44 KB
Volume: 15
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2008.12.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation Of Busulfan's Dose-Intensity

Evaluation Of Busulfan's Dose-Intensity In Patients Undergoing Allogeneic Stem Cell Transplantation (ASCT) With Two Different Fludarabine/Busulfan/ATG (FBA)-Based Reduced Intensity Conditioning (RIC) Regimens

✍ M. Hamadani; M. Craig; J. Abraham; W. Tse; A. Cumpston; C.J. Stotler; S.C. Remic 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Fludarabine, Antithymocyte Globulin, and

Fludarabine, Antithymocyte Globulin, and Very Low-Dose Busulfan for Reduced-Intensity Conditioning before Allogeneic Stem Cell Transplantation in Patients with Lymphoid Malignancies

✍ Florent Malard; Xavier Cahu; Aline Clavert; Eolia Brissot; Patrice Chevallier; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Allogeneic Stem Cell Transplantation fro

Allogeneic Stem Cell Transplantation from Matched Related Donor in Patients Over the Age of 55 Years After Reduced Intensity Conditioning Associating Fludarabine-Iv Busulfan and Rabbit-Antithymocyte Globulin: A Prospective Multicenter Phase II Clinical Trial with Socio Economic Evaluation

✍ D. Blaise; M. Mohty; N. Milpied; A.-G. Lecorroller-Soriano; N. Fegueux; S. Furst 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Five Versus 2.5 mg/kg of Anti-Thymocyte-

Five Versus 2.5 mg/kg of Anti-Thymocyte-Globulin Dose in Reduced-Intensity-Conditioning Reduces Acute and Chronic Graft-Versus-Host Disease for Patients with Myeloid Malignancies Undergoing Allogeneic Stem Cell Transplantation

✍ R. Devillier; R. Crocchiolo; L. Castagna; S. Fürst; J. El Cheikh; C. Faucher; T. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A Pilot Study of Reduced Intensity Condi

A Pilot Study of Reduced Intensity Conditioning (RI) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor Chimerism in Patients With Symptomatic Sickle Cell Disease (SCD)

✍ M. Bhatia; E. Morris; V. Moore; B. Tallamy; D. George; J.H. Garvin; P. Satwani; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 85 KB